Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Pulmonary Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Pulmonary Other
    Patients With Idiopathic Pulmonary Fibrosis at Increased Risk of Severe Coronary Events - (DGNews)
    MDCT Scans Offer Noninvasive Alternative to Bronchoscopy in Patients With Airway Stent Complications - (DGNews)
    Patients With Pulmonary Arterial Hypertension Who Discontinue Other Medications Due to Liver Abnormalities Fare Well With Ambrisentan: Presented at CHEST - (DGDispatch)
    Tadalafil Effective for Pulmonary Arterial Hypertension: Presented at CHEST - (DGDispatch)
    Ambrisentan Shows Long-Term Efficacy in Treatment of Pulmonary Hypertension: Presented at CHEST - (DGDispatch)

    News archive

     Recent webcasts/CME - Pulmonary Other
  • Improving the Standard of Care in Acute Hypertension
  • Management of Pulmonary Hypertension in Connective Tissue Disease

    Webcasts/CME archive

     Recent cases - Pulmonary Other
      Management Dilemma; A Woman with Cystic Fibrosis and Severe Lung Disease Presenting with Colonic Carcinoma: A Case Report
      Unilateral Hemothorax in a 46 Year Old South Indian Male Due to a Giant Arteriovenous Hemodialysis Fistula: A Case Report
      Transfusion Related Acute Lung Injury Presenting with Acute Dyspnoea: A Case Report
      Gemcitabine-Induced Pulmonary Toxicity During Adjuvant Therapy in a Patient with Pancreatic Cancer
      Massive Pulmonary Emboli Associated with Olanzapine

      Cases archive
        




      my personal edition > pulmonary other > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Effective Obstructive Sleep Apnea Treatment Reduces Risk Of Cardiovascular Disease

      A DGReview of :"Increased Incidence of Cardiovascular Disease in Middle-aged Men with Obstructive Sleep Apnea: A 7-Year Follow-up"
      American Journal of Respiratory and Critical Care Medicine

      07/30/2002
      By James Adams


      Middle-aged men with obstructive sleep apnea have an increased risk of developing cardiovascular disease. Effective treatment of obstructive sleep apnea can help eliminate this increase in risk, according to investigators.

      The investigators, from the Sleep Laboratory of the Department of Pulmonary Medicine at Sahlgrenska University Hospital in Gothenburg, Sweden, studied 60 men with and 122 men without obstructive sleep apnea. Subjects were 30 to 69 years old with a mean age of 46.8 years.

      None of the men were diagnosed with hypertension, cardiovascular disease, pulmonary disease, diabetes mellitus, psychiatric disorder, alcohol dependency or malignancy at the beginning of the study.

      During the seven-year follow-up period, cardiovascular disease developed in 22 of 60 men (36.7 percent) with obstructive sleep apnea compared with eight of 122 men (6.6 percent) without obstructive sleep apnea.

      The increased risk of cardiovascular disease in obstructive sleep apnea patients was independent of age, body mass index, systolic blood pressure, diastolic blood pressure and smoking status.

      Among 15 patients who received effective treatment for their obstructive sleep apnea, only one (6.6 percent) developed cardiovascular disease. In contrast, cardiovascular disease developed in 21 of 37 sleep apnea patients (56.8 percent) who received incomplete treatment.

      Multiple regression analysis revealed that efficient treatment of obstructive sleep apnea was associated with a significant reduction in the risk of cardiovascular disease.
      Am J Respir Crit Care Med 2002; 166(2): 159-165. "Increased Incidence of Cardiovascular Disease in Middle-aged Men with Obstructive Sleep Apnea: A 7-Year Follow-up"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send